Conjunctivitis Pharma Focus - Clinical Trial: Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis

This clinical trial will determine moxifloxacin's efficacy for treating bacterial conjunctivitis.

Study Type: Interventional

Age/Gender Requirements: 1 month+ (male/female)

Sponsor: Alcon Research

Purpose: To evaluate the safety and efficacy of Moxifloxacin AF Ophthalmic Solution in comparison to Moxifloxacin AF Vehicle for treating bacterial conjunctivitis.

Click here to access this third-party resource.

Related Videos
Brian LaMoreaux, MD | Credit: Horizon Therapeutics
Experts on inflammatory bowel disease.
Experts on inflammatory bowel disease.
Victor Kim, MD: Addressing Comorbidities and Advancing COPD Care
Related Content
© 2023 MJH Life Sciences

All rights reserved.